News
Pipette and cells

HEPNOU PROJECT

Posted by Readycell on  March 21, 2018

Comments Off on HEPNOU PROJECT
Category: news
R&D Projects: developing different products based on the same cellular origin The main objective for this project involves the completion of the set of HepatoReady products, iniciated in 2014 (Project financed by ACCIÓ, numer RD14 1-0087) and includes the following technical objectives: 1. Develop a method that allows isolated hepatocyte cryopreservation from human tissue, that constitutes a better option for their long term storage, and it offers a permanent supply of product. 2. Develop a

Incorporation of new R&D Manager

Posted by Readycell on  December 5, 2017

Comments Off on Incorporation of new R&D Manager
Category: news
Expanding R&D staff and activities ReadyCell is pleased to announce its newest member Dr. María Vázquez-Sánchez, who joins ReadyCell team as a Head of R&D. Within her role, María will support the development of new in-vitro, ready-to-use tools, for ADME/DMPK studies. Welcome on board, María!
ReadyCell was in BioJapan

Participating in BioJapan 2017 in Yokohama

Posted by Readycell on  October 8, 2017

Comments Off on Participating in BioJapan 2017 in Yokohama
Category: news
Internationalization is a core value of our business ReadyCell’s representatives participated in the BioJapan 2017 held in Yokohama (11-13 October) in order to meet local and international companies to penetrate the Japanese market with our unique shipping technologies and ready-to-use kits for ADME studies. We would like to thank ACCIÓ and ASEBIO for supporting ReadyCell during this journey and for helping us meet interesting companies during our stay, and also to the organizers to allow
Map of the United Kingdom

Business Trip to the United Kingdom

Posted by Readycell on  May 18, 2017

Comments Off on Business Trip to the United Kingdom
Category: news
Crossing the Channel to show our added value ReadyCell committed to visit key customers and potential new clients in the British territory, in order to raise awareness of our existing products as well as to receive feedback from Key Opinion Leaders from the Bioscience sectors. ReadyCell’s representatives will travel to important UK cities such as Nottingham, Cambridge and London, and visit companies such as Sygnature Discovery, Pharmaron UK, and Astex Therapeutics as key companies in

ReadyCell Partnering in China

Posted by Readycell on  May 9, 2014

Comments Off on ReadyCell Partnering in China
Category: news
Developing new international partnerships After different contacts along 2013, last month ReadyCell visited several companies during a Chinese tour. With the aim to promote its implantation in the Asian market, and being a hub for R&D and CRO services, Shanghai and Beijing were the cities chosen for this partnering trip. ReadyCell representatives met CEOs, CSOs and ADME Directors from key Chinese companies as Wuxi App Tec, Joinn Laboratories, Shanghai Medicilon and PharmaLegacy. Thanks to ReadyCell